IL-20 Controls Resolution of Experimental Colitis by Regulating Epithelial IFN/STAT2 Signaling

Scientists investigated the role of interleukin (IL)-20 in inflammatory bowel disease and experimental colitis. In vivo imaging, high-resolution mini-endoscopy, and histology were used to assess intestinal inflammation.